Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1996-10-31
|
pubmed:abstractText |
The mechanism of action of MD1, a new biotechnological radiotherapeutic agent of plant origin, on smooth muscle contraction was investigated. Contraction induced by MD1 consists of an initial dose-dependent transient phasic response (PR) (with ED50 = 0.11 +/- 0.02%, n = 4, the time of rise 15 s, onset of decay about 30 s) followed by a tonic contraction (TC) (at 10% MD1 only) with a maximum in 20 min (0.78 +/- 0.07 x the maximum contraction induced by 110 mmol/l KCl, n = 8, (TC/PR) = 0.94 +/- 0.11, n = 5). If the vessel was washed out during this maximum, the maximum tension was maintained for up to 2 h ("long-lasting" tension) and was abolished after perfusion with Ca(2+)-free EGTA solution (E) or H7 (0.05 mmol/l) solution. With solution E being applied 30 min before 10% MD1-induced contraction, TC was reduced by 92 +/- 3% (n = 4) in contrast to PR being reduced by 48 +/- 5% (n = 5). During TC, calcium appeared to penetrate into cells through receptor operated channels, since tension neither depended on verapamil (0.05 mmol/l) nor cobalt (up to 10 mmol/l). In solution H7 (with 10 min pretreatment), PR and TC were almost completely inhibited. It is proposed that MD1 activates the C-kinase branch of the calcium messenger system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Cobalt,
http://linkedlifedata.com/resource/pubmed/chemical/Egtazic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Plant Extracts,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Chloride,
http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0231-5882
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
293-303
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8720693-Animals,
pubmed-meshheading:8720693-Calcium,
pubmed-meshheading:8720693-Cobalt,
pubmed-meshheading:8720693-Dose-Response Relationship, Drug,
pubmed-meshheading:8720693-Egtazic Acid,
pubmed-meshheading:8720693-Isometric Contraction,
pubmed-meshheading:8720693-Kinetics,
pubmed-meshheading:8720693-Muscle, Smooth, Vascular,
pubmed-meshheading:8720693-Plant Extracts,
pubmed-meshheading:8720693-Potassium Chloride,
pubmed-meshheading:8720693-Rana temporaria,
pubmed-meshheading:8720693-Time Factors,
pubmed-meshheading:8720693-Vasoconstriction,
pubmed-meshheading:8720693-Vasoconstrictor Agents,
pubmed-meshheading:8720693-Venae Cavae
|
pubmed:year |
1995
|
pubmed:articleTitle |
Mechanisms of vasoconstriction induced in frog vascular smooth muscle by MD1, a new biotechnological agent.
|
pubmed:affiliation |
Sechenov Institute of Evolutionary Physiology and Biochemistry, Academy of Sciences of Russia, St. Petersburg. Sobol@IEF.SPB.SU
|
pubmed:publicationType |
Journal Article,
In Vitro
|